HIFU is a viable option within a shared decision-making framework for fertility-preserving management of placenta accreta spectrum (PAS) disorder. In conservatively managed cases, HIFU achieved spontaneous placental expulsion in 44.1% of patients; however, 55.9% ultimately required additional intervention, underscoring the need for close coordination with curettage or hysteroscopy. Larger prospective multicenter studies are warranted to establish optimal patient selection criteria and to validate long-term reproductive outcomes.
Long et al. (Mon,) studied this question.